Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Supplemental NDA filed for Novantrone in U.S.

May 17, 1996

Platinum complexes claimed by Nippon Kayaku

May 17, 1996

Rb gene therapy for bladder cancer described at urology meeting

May 10, 1996

Receptagen discovers vitamin B12 uptake inhibitor

May 10, 1996

New cytokine purified by Japanese investigators

May 10, 1996

Compassion use trial of PN 27.1 in prostate cancer patients underway

May 10, 1996

Hybridon will file IND for antisense PKA down-regulator

May 10, 1996

SunPharm to test DEHOP in cancer patients

May 10, 1996

Oncolysin B effective in tumor models in mice; phase II trials underway

May 10, 1996

Agouron reports phase II data for Thymitaq

May 3, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Nov. 12, 2024.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for November 12, 2024.
Sales balloon for GLP-1 drugs from Novo Nordisk, Eli Lilly
BioWorld
Nearly $3.8 billion was earned by Novo Nordisk A/S and Eli Lilly and Co. in the third quarter for their glucagon-like peptide-1 (GLP-1) drugs to treat obesity....
Regulatory actions for Oct. 31, 2024
BioWorld
Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Capsida, Electra,...
Australia reimburses Vazkepa a decade after US approval
BioWorld
For the first time, Australians have access to CSL Inc.’s Vazkepa (icosapent ethyl/Vascepa) for managing cardiovascular disease more than a decade after the drug...

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.